Athanor Capital, LP - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 174 filers reported holding ROCKET PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 2.61 and the average weighting 0.4%.

Quarter-by-quarter ownership
Athanor Capital, LP ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$303,000
-10.4%
6,819
+10.7%
0.01%
-12.5%
Q4 2020$338,000
+68.2%
6,159
-30.1%
0.01%0.0%
Q3 2020$201,000
-17.3%
8,810
-24.3%
0.01%
-33.3%
Q2 2020$243,000
-1.2%
11,631
+7.7%
0.01%
+9.1%
Q4 2019$246,00010,8010.01%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 16,812,491$234,534,00010.10%
TANG CAPITAL MANAGEMENT LLC 2,965,485$41,369,0005.81%
Ghost Tree Capital, LLC 650,000$9,068,0002.40%
Boxer Capital, LLC 1,466,051$20,451,0001.39%
Vivo Capital, LLC 860,648$12,006,0001.09%
Samsara BioCapital, LLC 128,197$1,788,0001.03%
Cormorant Asset Management, LP 1,568,550$21,881,0001.02%
Perceptive Advisors 2,189,010$30,537,0000.80%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,677,367$23,399,0000.74%
Eventide Asset Management 1,415,000$19,739,0000.64%
View complete list of ROCKET PHARMACEUTICALS INC shareholders